Cepheid, founded in 1996 and now part of the Danaher Corporation based in Washington, D.C., is famous for its GeneXpert System. The cutting-edge technology packs all the lab processes needed for ...

Recent life science and diagnostic acquisitions have included Beckman Coulter, Pall, and Cepheid. In early 2020, Danaher completed the acquisition of GE Biopharma, now called Cytiva, which fills ...

Danaher Corporation DHR has been benefiting ... Solid momentum and market share gains for its Cepheid business bode well for ...

Cepheid's Multiplex Panel enables physicians ... talented team and strong balance sheet, all powered by the Danaher Business System, we feel well-positioned to deliver long-term shareholder ...

KKR builds stake in Henry Schein, reaches deal to add board seats Danaher on Wednesday missed Wall Street estimates for fourth-quarter profit due to soft demand for tools and services used in drug ...

Cepheid's Respiratory Revenue ... First Quarter 2025 Adjusted Operating Profit Margin Expectation: Approximately 26.5%. Danaher Corp (NYSE:DHR) reported better-than-anticipated core revenue ...

Analysts' ratings for Danaher (NYSE:DHR) over the last quarter vary from bullish to bearish, as provided by 5 analysts. The table below provides a concise overview of recent ratings by analysts ...

Matt McGrew; Executive Vice President and Chief Financial Officer; Danaher Corp My name is Madison, and I will be your conference facilitator this morning. At this time, I would like to welcome ...